Profile
Andrew James Webb is currently the Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd.
and the Chief Executive Officer at CRISM Therapeutics Corp.
He is also a Director at Novel Technologies Holdings Ltd.
since 2017.
Previously, he was a Director at Convert2Green Ltd.
Andrew James Webb active positions
| Companies | Position | Start |
|---|---|---|
Novel Technologies Holdings Ltd.
 Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | 2017-11-22 |
Former positions of Andrew James Webb
| Companies | Position | End |
|---|---|---|
Convert2Green Ltd.
 Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Convert2Green Ltd. provides renewable fuel solution. The company was founded on October 10, 2006 and is headquartered in Shrewsbury, the United Kingdom. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Convert2Green Ltd. provides renewable fuel solution. The company was founded on October 10, 2006 and is headquartered in Shrewsbury, the United Kingdom. | Process Industries |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom. | Finance |
- Stock Market
- Insiders
- Andrew James Webb
